"Learn about the importance of kidney health and comprehensive screening during National Kidney Month. Discover how CarelonRx ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...

In patients with CKD, hyperkalemia significantly increases risk for major adverse cardiovascular events and arrhythmia.

“The KDIGO 2024 guideline navigates clinicians through the identification, improved evaluation, and targeted treatment and management of persons with CKD,” the authors write. “Evaluation of ...

diagnosis, and potential treatment of acute kidney injury (AKI) and chronic kidney disease (CKD). The findings emphasize the importance of exosomal lncRNAs, which function as molecular regulators ...

Non-Hispanic Black populations face the highest risk of death from chronic kidney disease (CKD)–associated cardiac arrest, a ...

Researchers in Israel have tested a potential treatment for chronic kidney disease (CKD) in dogs.The study, published i ...

Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 on evaluation and ...

A new review published in Genes & Diseases on long non-coding RNAs (lncRNAs) highlights their critical role in the development, diagnosis, and potential treatment of acute kidney injury (AKI) and ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.